This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Blue Cross Blue Shield immune from heart-monitor suit under McCarran-Ferguson Act, US judge rules

By Max Fillion ( December 29, 2020, 20:20 GMT | Insight) -- An antitrust suit accusing Blue Cross Blue Shield and five of its health insurance administrators of conspiring to block remote heart-monitoring devices from insurance coverage is barred by the McCarran-Ferguson Act, a US judge ruled.An antitrust suit accusing Blue Cross Blue Shield and five of its health insurance administrators of conspiring to block remote heart-monitoring devices from insurance coverage is barred by the McCarran-Ferguson Act, a US judge ruled....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections